Published May 18, 2012 on InjuryBoard DePuy ASR hip implant patients in most states who do not file lawsuits before August 23, 2012 may lose their rights to compensation or…
Read More
Claims targeted at DePuy, a unit of Johnson & Johnson, over their ASR hip implant may soon be settled following the announcement of a $4 billion agreement intended to settle…
Read More
Political lobbying may have trumped FDA scientists’ opinions during the approval process for the medical device Menaflex, the Wall Street Journal reported March 6. According to the newspaper, internal documents…
Read More
DePuy President, Andrew Ekdahl, delivered testimony during day three of Strum v. DePuy, a case being heard in a Chicago state court. The DePuy ASR Hip lawsuit involves Carol Strum,…
Read More
In 2010, DePuy recalled two types of hip replacements, the ASR XL Acetabular System and the ASR Hip Resurfacing System. DePuy Orthopaedics is a subsidiary of Johnson & Johnson. DePuy…
Read More
Published May 8, 2012 on TMD A loophole in federal law requires the FDA to approve some previously-recalled medical devices. Now, the agency says it wants to see that changed.…
Read More
Following a study whose data revealed an unusually high failure rate of 43 percent for certain types of metal-on-metal hip implants, the UK has prohibited the use of these types…
Read More
On the heels of Johnson & Johnson's loss in a California Superior Court case regarding their DePuy ASR Hip implant, the second DePuy ASR Hip lawsuit started on March 11…
Read More
Of late, it has been widely reported that Johnson & Johnson and DePuy have agreed to a $4 billion settlement of thousands of DePuy ASR hip lawsuits that have been…
Read More
Now a recalled device , the DePuy ASR hip replacement has significantly changed the lives of thousands of people around the world, and not in the way for which it…
Read More